当前位置: 首页 > 期刊 > 《中国美容医学》 > 202009
编号:13842580
血管生成素-2上调增强血管瘤干细胞血管形成能力的研究(3)
http://www.100md.com 2020年5月1日 《中国美容医学》 202009
     [5]Peterson TE,Kirkpatrick ND,Huang Y,et al.Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages[J].Proc Natl Acad Sci U S A,2016,113(16): 4470-4475.

    [6]Munabi NCO,England RW,Edwards AK,et al.Propranolol targets hemangioma stem cells via cAMP and mitogen-activated protein kinase regulation[J].Stem Cells Transl Med,2016,5(1):45-55.

    [7]Mong EF,Akat KM,Canfield J,et al.Modulation of LIN28B/Let-7 signaling by propranolol contributes to infantile hemangioma involution[J].Arterioscler Thromb Vasc Biol,2018,38(6):1321-1332.

    [8]Moritz F,Schniering J,Distler JHW,et al.Tie2 as a novel key factor of microangiopathy in systemic sclerosis[J].Arthritis Res Ther,2017,19(1):105.

    [9]Viallard C,Larrivée B.Tumor angiogenesis and vascular normalization: alternative therapeutic targets[J].Angiogenesis,2017,20(4):409-426.

    [收稿日期]2019-12-25

    本文引用格式:張明亮,吴杉英,王彪,等.血管生成素-2上调增强血管瘤干细胞血管形成能力的研究[J].中国美容医学,2020,29(9):89-91., 百拇医药(张明亮 吴杉英 王彪 刘照亮 雷忱)
上一页1 2 3